Anbison has a professional R&D team specializing in developing high-end finished dosage forms, composed of scientists, technicians and researchers who have extensive experience from multinational pharmaceutical companies and leading domestic companies. Anbison owns several high-end formulation platform and is familiar with the patent and registration of China, the United States and Europe. Anbison holds independent intellectual property rights (IIPR) for multiple techniques and has rich experience and successful cases in patent challenging.